Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, 6-week, Randomised, Double-blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK Asian Subjects With Primary Hypercholesterolaemia

NCT00427960 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00427960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00427960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, 6-week, Randomised, Double-blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK Asian Subjects With Primary Hypercholesterolaemia
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2006
Completion date
February 29, 2008
Enrollment
55 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolaemia